Cardiovascular diseases and Xenical
According to a Study made at the “European Congress on Obesity” (ECO) in Budapest, Xenical not only reduces considerable weight on obese persons, it also improves the cardiovascular risk factors, such as arterial pressure, glycemic control and lipid profile on patients suffering from type II diabetes and hypertension.
This way we can see that Xenical (orlistat 120mg) not only helps fight overweight and obesity, but It also offers important benefits to patients with two of the most serious diseases, diabetes and hypertension.
Evidence from Studies of the “World Health Organization” (WHO) states that approximately 1.600 millions adults are overweight, of which at least 400 million are obese.
Obesity is not just an aesthetic issue; this disease is directly related with many others that might be a threat to life; such as:
-Cardiovascular: one of the main causes of death, worldwide.
-Diabetes: this disease estimates an increased risk of 50% of deaths in the next 10 years.
-Hypertension: cardiovascular diseases risk factor.
-Cholesterol: also a cardiovascular diseases risk factor.
In the ECO study, 2.692 overweighed patients were recruited; some of them were treated with Xenical and some others with a Placebo, demonstrating a considerable improvement in:
- Arterial pressure: 15, 3% of Xenical treated patients had normal results, opposite to the 8, 7% placebo treated patients.
- Blood glucose levels
- Insulin
- Glucose dissolved
- Total Cholesterol
Patients treated with Xenical doubled their weight loss compared to the placebo treated patients, which was also notable in the waist circumference reduction.
On patients with normal results to the treatment (weight loss of 5 %- up to three months) Xenical produced arterial pressure changes, insulin, dissolved glucose, and weight opposite to the placebo.
Arterial pressure normalization on patients treated with Xenical was more than the double than the placebo treated patients.
No comments yet.